Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Phoenix Ho, MD
Seagen Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
128 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Adelaide Hospital
Adelaide, Australia
- Monash Medical Centre
Clayton, Australia
- St George Hospital
Kogarah, Australia
- Royal Perth Hospital
Perth, Australia
- Sunshine Hospital
St Albans, Australia
- Lkh Salzburg, Universitatsklinikum Der Pmu
Salzburg, Austria
- Klinikum Wels-Grieskirchen Gmbh
Wels, Austria
- Ziekenhuis Netwerk Antwerpen Campus Stuivenberg
Antwerp, Belgium
- Az Sint-Jane Brugge - Oostende Av - Campus Sint-Jan
Bruges, Belgium
- Cliniques Universitaires Saint Luc
Brussels, Belgium
- Institut Jules Bordet
Brussels, Belgium
- Centre Hospitalier Universitaire Sart Tilman Liege
Liège, Belgium
- Az Delta - Campus Wilgenstraat
Roeselare, Belgium
- Cliniques Universitaires Ucl de Mont-Goddine
Yvoir, Belgium
- Fakultni Nemocnice Brno
Brno, Czechia
- Fakultni Nemocnice Hradec Kralove-Oddeleni Klinicke Hematologie
Hradec Králové, Czechia
- Fakultni Nemocnice Ostrava
Ostrava - Poruba, Czechia
- Ustav Hematologie A Krevni Transfuze
Prague, Czechia
- Chu Amiens Picardie - Site Sud
Amiens, France
- Center Hospitalier Universitaire D' Angers
Angers, France
- Centre Hospitalier Victor Dupouy D'Argenteuil
Argenteuil, France
- Centre Hospitalier Universitaire Hopital Avicenne
Bobigny, France
- Hopital D'Instruction Des Armees - Percy
Clamart, France
- Chru de Lille
Lille, France
- Centre Hospitalier Universitaire (chu) de Limoges - Hopital Dupuytren
Limoges, France
- Hopital Emile Muller
Mulhouse, France
- Centre Hospitalier Universitaire Nantes-Hotel Dieu
Nantes, France
- Chu de Nice - Hopital L'Archet
Nice, France
- Hopital Saint-Louis / Service D'Hematologie
Paris, France
- Chu Bordeaux Hopital Haut-Levaque
Pessac, France
- Centre Hospitalier Lyon Sud
Pierre-Bénite, France
- Centre Hospitalier Universitaire de Poitiers
Poitiers, France
- Centre Hospitalier Universitaire de Rennes, Hopital Pontchaillou
Rennes, France
- Stadtisches Klinikum Braunschweig Ggmbh
Braunschweig, Germany
- Universitatsklinikum Koln
Cologne, Germany
- Marien Hospital Dusseldorf Gmbh
Düsseldorf, Germany
- Universitatsklinik Freiburg
Freiburg im Breisgau, Germany
- Universitatsklinikum Schleswig-Holstein
Kiel, Germany
- Semmelweis Egyetem
Budapest, Hungary
- Debreceni Egyetem Orvos és Egeszsegtudomanyi Centrum, Iii. Sz. Belgyogyaszati Klinika
Debrecen, Hungary
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2016
- Primary completion
- 3 Oct 2017
- Completion
- 3 Oct 2017
- Last update posted
- 12 Dec 2018
- Registered enrollment
- 240
- Registry id
- NCT02785900
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.